Upon Approval of NDA Quoin Will Receive Seven Years Marketing Exclusivity for QRX003 in the US Orphan Drug Designation previously…
Dynamic Digital Radiography - Shoulder Series DDR is a novel, low-dose X-ray imaging technique available on Konica Minolta Healthcare DR…
PALO ALTO, CA / ACCESS Newswire / October 21, 2025 / Bioz, Inc., a pioneering AI platform changing the way…
Black Book survey reveals just 1 in 4 hospitals can fully exchange patient data across national boundaries in Q4 2025…
Technology Partnership Improves Patient Outcomes in Healthcare Through Advanced Video API and Virtual Nursing Solutions HOLMDEL, N.J., Oct. 20, 2025…
First dual-acting anti-inflammatory and anti-fibrotic candidate in development for FSCD, a condition with no approved therapies Topline safety, PK, and…
NEW YORK--(BUSINESS WIRE)--Oscar Health, Inc. (NYSE: OSCR), a leading healthcare technology company, is introducing a suite of easy-to-use health plans…
Small cell lung cancer (SCLC) accounts for 15% of all lung cancers and remains an aggressive disease with median survival…
Palazestrant in combination with ribociclib demonstrated encouraging activity across all dose cohorts and subgroups Median PFS was 15.5 months in…
Novel regimen GO-4, combining melphalan, BCNU, hydroxocobalamin, ascorbic acid, and autologous stem cells shows manageable adverse reactions and a strong signal of efficacy in patients with BRCA-related…